In general, raised levels of COX-2 and 12-lipoxygenase (12-LOX) in patients who developed metastatic disease or local recurrence and/or died have been found in other studies and, therefore, these enzymes have been proposed as biomarkers in cancer [146,147]. Here, ALOX15 is linked to cancer.